858-449-1310 contact@somatek.com

BLOG

CAR-T Cells: Cool new poster

Got empty wall space in your lab or hallway? Consider decorating with the new timely “Chimeric Antigen Receptor (CAR)-T Cell in Immunotherapy” poster available from Novus Biologicals.  https://www.novusbio.com This wall poster provides an overview of Chimeric Antigen...

read more

A novel recombinant protein for treatment of stroke

Stroke is the fifth leading cause of death in the United States and the number one cause of adult disability. Acute ischemic strokes occur when a clot blocks blood flow to the brain. To date, the FDA has approved only one drug treatment, called tissue plasminogen...

read more

FDA’s Top Ten Drug GMP Citations

Stroke is the fifth leading cause of death in the United States and the number one cause of adult disability. Acute ischemic strokes occur when a clot blocks blood flow to the brain. To date, the FDA has approved only one drug treatment, called tissue plasminogen...

read more

Chromatographical Joke

Summing up the good, the bad and the ugly for the past year Genetic Engineering & Biotechnology News recently published a retrospective on 2017 clinical trial failures written by GEN contributor Alex Philippidis.
read more

FDA approves 19 biological licenses in 2017

Somatek is pleased to announce the launch of its new website with improved functionality, fresh graphic design and new content. Many thanks to Sanne Wesselman and AtoZmarketing for expert support in setting up the new site. Please visit us often for updates and to see...

read more